UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002903
Receipt number R000003519
Scientific Title Study on the effect of caffeine intake on tear production and its correlation with genetic variation
Date of disclosure of the study information 2009/12/24
Last modified on 2012/09/24 16:42:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the effect of caffeine intake on tear production and its correlation with genetic variation

Acronym

Study on the effect of caffeine intake on tear production

Scientific Title

Study on the effect of caffeine intake on tear production and its correlation with genetic variation

Scientific Title:Acronym

Study on the effect of caffeine intake on tear production

Region

Japan


Condition

Condition

Dry eye

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To evaluate the effect of caffeine intake on tear production and its correlation with genetic variations.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Tear meniscus height

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Caffeine (Washout) Placebo

Interventions/Control_2

Placebo (Washout) Caffeine

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

Normal adults

Key exclusion criteria

Patients with dry eye of moderate degree or more.
Schirmer test value of 5 mm or less.
Tear breakup time of 5 seconds or less.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shiro Amano

Organization

University of Tokyo Hospital

Division name

Department of Corneal Transplantation

Zip code


Address

7-3-1 Hongo, Bunkyo-ku, Tokyo

TEL

03-5800-5109

Email



Public contact

Name of contact person

1st name
Middle name
Last name Shiro Amano

Organization

University of Tokyo Hospital

Division name

Department of Corneal Transplantation

Zip code


Address

7-3-1 Hongo, Bunkyo-ku, Tokyo

TEL

03-5800-5109

Homepage URL


Email

amanos-tky@umin.ac.jp


Sponsor or person

Institute

University of Tokyo Hospital, Department of Corneal Transplantation

Institute

Department

Personal name



Funding Source

Organization

Self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京大学医学部附属病院(東京都)、前田眼科医院(福島県)


Other administrative information

Date of disclosure of the study information

2009 Year 12 Month 24 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Arita R, Yanagi Y, Honda N, Maeda S, Maeda K, Kuchiba A, Yamaguchi T, Yanagihara Y, Suzuki H, Amano S. Caffeine increases tear volume depending on polymorphisms within the adenosine A2a receptor gene and cytochrome P450 1A2. Ophthalmology119:972-978, 2012

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 08 Month 01 Day

Date of IRB


Anticipated trial start date

2007 Year 08 Month 01 Day

Last follow-up date

2009 Year 12 Month 01 Day

Date of closure to data entry

2009 Year 12 Month 01 Day

Date trial data considered complete

2009 Year 12 Month 01 Day

Date analysis concluded

2009 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2009 Year 12 Month 15 Day

Last modified on

2012 Year 09 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003519


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name